{
    "Trade/Device Name(s)": [
        "FREND\u2122 Vitamin D Test System"
    ],
    "Submitter Information": "NanoEnTek, Inc.",
    "510(k) Number": "K162754",
    "Predicate Device Reference 510(k) Number(s)": [
        "K110619"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MRG"
    ],
    "Summary Letter Date": "November 23, 2016",
    "Summary Letter Received Date": "November 28, 2016",
    "Submission Date": "January 6, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1825"
    ],
    "Regulation Name(s)": [
        "Vitamin D test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "25-hydroxy vitamin D",
        "related hydroxylated metabolites"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (K3 EDTA)",
        "Plasma (lithium heparin)",
        "Plasma (citrate)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FREND\u2122 System",
        "FREND\u2122 AP System"
    ],
    "Method(s)/Technology(ies)": [
        "Fluorescent immunoassay",
        "Competitive immunoassay",
        "Microfluidics lateral flow"
    ],
    "Methodologies": [
        "Quantitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Cartridge",
        "Reagent",
        "Code chip",
        "Tube"
    ],
    "Document Summary": "FDA 510(k) summary for NanoEnTek FREND\u2122 Vitamin D Test System, a fluorescent immunoassay for quantitative measurement of 25-hydroxy vitamin D in serum and plasma using FREND\u2122 platforms",
    "Indications for Use Summary": "Intended for the quantitative measurement of 25-hydroxy vitamin D and related hydroxylated metabolites in human serum and plasma to aid in the assessment of vitamin D sufficiency; for use in clinical laboratories, not for point-of-care settings",
    "fda_folder": "Clinical Chemistry"
}